剂量,剂量速率和分剂量会影响光子FLASH辐射后的小鼠皮肤反应
Kathryn H Brown1, Mihaela Ghita-Pettigrew1, Malachy P McIvor1
1Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Northern Ireland, UK.
概括
光子FLASH放射治疗 (FLASH-RT) 显示出正常组织节约的潜力,类似于质子和电子束. 这项研究证实了使用光子的可行性,剂量和剂量率是影响放射生物反应的关键因素.
科学领域:
- 辐射瘤学 辐射瘤学
- 临床前研究 临床前研究
- 医学物理 医学物理
背景情况:
- 与传统 (CONV) 暴露相比,FLASH辐射疗法 (FLASH-RT) 使用超高剂量率来节省正常组织.
- 大多数FLASH-RT研究都使用了电子和质子,对光子FLASH反应的研究有限.
- 鉴于光子的广泛临床使用,描述光子FLASH效应至关重要.
研究的目的:
- 通过使用新型光子FLASH系统 (FLASH-SARRP) 研究剂量,剂量速率和分剂量对小鼠皮肤毒性的影响.
- 在黑色素瘤异种移植模型中,将光子FLASH-RT与CONV暴露的疗效进行比较.
主要方法:
- 在C57BL/6小鼠中,在CONV (3.2 Gy/min) 和FLASH (72 Gy/s) 剂量速率下评估了皮肤毒性.
- 放射后8-12周进行了组织病理学分析和视觉评分.
- 使用B16-F10黑色素瘤异种移植模型评估了瘤生长延迟.
主要成果:
- 与CONV暴露相比,FLASH暴露延迟了皮肤毒性,并减少了增生和纤维化 (p < 0.01).
- 在FLASH-RT中观察到剂量依赖的节约效应,但分剂量暴露减少了这种节约.
- 光子FLASH-RT证明了与CONV暴露 (p = 0.99) 相比的瘤控制疗效.
结论:
- 光子FLASH-RT是可行的,并且实现了与质子和电子FLASH-RT相比的正常组织节约.
- 调节对光子FLASH的放射生物反应的关键参数包括剂量,平均剂量速率和束结构.
更多相关视频
相关概念视频
Dose Size and Dosing Frequency: Determination Methods
279
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
279
Dose-Response Relationship: Potency and Efficacy
6.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.4K


